"Are you at risk for hereditary breast cancer?": Development of a personal risk assessment tool for hereditary breast and ovarian cancer

Journal of Genetic Counseling

Volumn 17, Issue 1, 2008, Pages 64-78

  Cohn, Wendy F ^a   Jones, Susan M ^b   Miesfeldt, Susan ^a,c  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MAINE MEDICAL CENTER   (United States)

Author keywords

Education; Genetic counseling; Hereditary breast and ovarian cancer; Hereditary breast cancer; Risk assessment

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; EDUCATION PROGRAM; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HERITABILITY; HUMAN; INFORMATION DISSEMINATION; MEDICAL EDUCATION; MEDICAL INFORMATION; OVARY CANCER; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST; SELF EVALUATION; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDICAL HISTORY TAKING; MUTATION; OVARIAN NEOPLASMS; RISK ASSESSMENT;

EID: 39149091010     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-007-9125-0     Document Type: Article

References (69)

1. Acheson, L. S., Wiesner, G. L., Zyzanski, S. J., Goodwin, M. A., & Stange, K. C. (2000). Family history-taking in community family practice: implications for genetic screening. Genetics in Medicine, 2, 180-185.
2. Acheson, L. S., Zyzanski, S. J., Stange, K. C., Deptowicz, A., & Wiesner, G. L. (2006). Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. Journal of Clinical Oncology, 34, 5395-5402.
3. Andermann, A. A. J., Austoker, J., Watson, E. K., Lucassen, A. M., & MacKay, J. (2002). Development and evaluation of a general information leaflet for women with a family history of breast cancer. Journal of Cancer Education, 17, 155-160.
4. Antoniou, A., Pharoah, D. P., Narod, S., Risch, H. A., Egfjord, J. E., & Hopper, J. L., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. American Journal of Human Genetics, 72, 1117-1130.
5. Baty, B. J., Kinney, A. Y., & Ellis, S. M. (2003). Developing culturally sensitive cancer genetics communication aids for African Americans. American Journal of Human Genetics, 118A, 146-155.
6. Bosompra, K., Flynn, B. S., Ashikaga, T., Rarikar, C. J., Worden, J. K., & Solomon, L. J. (2000). Likelihood of undergoing genetic testing for cancer risk population-based study. Preventive Medicine, 30, 155-166.
7. Bradbury, A. R., & Olopade, O. I. (2007). Genetic susceptibility to breast cancer. Reviews in Endocrinology and Metabolic Disorders, 8, 255-267.
8. Breast Cancer Linkage Consortium (1999). Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute, 15, 1310-1316.
9. Brose, M. S., Rebbeck, T. R., Calzone, K. A., Stopfer, J. E., Nathanson, K. L., & Weber, B. L. (2002). Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute, 94, 1365-1372.
10. Chen, S., & Parmigiani, G. (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology, 25, 1329-33.
11. Claus, E. B., Schildkaraut, J. M., Thompson, W. D., & Risch, N. J. (1996). The genetic attributable risk of breast and ovarian cancer. Cancer, 77, 2318-2324.
12. Dick, W., & Carey, L. (1996). The systematic design of instruction. New York: Harper Collins Publishers, Inc.
13. Domchek, S. M., & Weber, B. L. (2006). Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene, 25, 5825-5831.
14. Dominguez, F. J., Jones, J. L., Zabicki, K., Smith, B. L., Gadd, M. A., & Specht, M., et al. (2005). Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer, 104, 1849-1853.
15. Donovan, K. A., & Tucker, D. C. (2000). Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. Journal of Behavioral Medicine, 23, 15-36.
16. Durfy, S. J., Buchanan, T. E., & Burke, W. (1998). Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing. American Journal of Human Genetics, 73, 82-87.
17. Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., & Daly, P. A., et al. (1997). Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. American Journal of Human Genetics, 61, 120-128.
18. Epplein, M., Koon, K. P., Ramsey, S. D., & Potter, J. D. (2005). Genetic services for familial cancer patients: A follow-up survey of National Cancer Institute Cancer Centers. Journal of Clinical Oncology, 23, 4713-4718.
19. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., & Bishop, D. T., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics, 62, 676-689.
20. Friedman, L. C., Cooper, P., Webb, J. A., Weinberg, A. D., & Plon, S. E. (2003). Primary care physicians' attitudes and practices regarding cancer genetics: A comparison of 2001 with 1996 survey results. Journal of Cancer Education, 18, 91-94.
21. Green, M. J., Biesecker, B. B., McInerney, A. M., Mauger, D., & Fost, N. (2001a). An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. American Journal of Medical Genetics, 103, 16-23.
22. Green, M. J., & Fost, N. (1997). An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. Journal of Cancer Education, 12, 204-208.
23. Green, M. J., McInerney, A. M., Biesecker, B. B., & Fost, N. (2001b). Education about genetic testing for breast cancer susceptibility: Patient preferences for a computer program or genetic counselor. American Journal of Medical Genetics, 103, 24-31.
24. Green, M. J., Peterson, S. K., Baker, M. W., Friedman, L. C., Harper, G. R., & Rubinstein, W. S., et al. (2005). Use of an educational computer program before genetic counseling for breast cancer susceptibility: Effects on duration and content of counseling sessions. Genetics in Medicine, 7, 221-229.
25. Green, M. J., Peterson, S. K., Baker, M. W., Harper, G. R., Friedman, L. C., & Rubinstein, W. S., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA, 292, 442-452.
26. Gribble, J. N. (1999). Informed consent documents for BRCA1 and BRCA2 screening: How large is the readability gap. Patient Education and Counseling, 38, 175-183.
27. Hayflick, S. J., Eiff, M. P., Carpenter, L., & Steinberger, J. (1998). Primary care physicians' utilization and perceptions of genetics services. Genetics in Medicine, 1, 13-21.
28. Honda, K. (2003). Who gets the information about genetic testing for cancer risk? The role of race/ethnicity, immigration status, and primary care clinicians. Clinical Genetics, 64, 131-136.
29. Honda, K., & Neugut, A. I. (2004). Associations between perceived cancer risk and established risk factors in a national community sample. Cancer Detection and Prevention, 28, 1-7.
30. Hoskins, K. F., Zwaagstra, A., & Ranz, M. (2006). Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer, 107, 769-778.
31. Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., & Barter, J., et al. (1997). Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education and Counseling, 32, 51-62.
32. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Smigal, C., et al. (2006). Cancer statistics, 2006. CA Cancer Journal for Clinicians, 56, 106-130.
33. Jones, J. L., Hughes, K. S., Kopans, D. B., Moore, R. H., Howard-McNatt, M., & Hughes, S. S., et al. (2005). Evaluation of hereditary risk in a mammography population. Clinical Breast Cancer, 6, 38-44.
34. Kaufman, E. M., Peshkin, B. N., Lawrence, W. F., & Shelby, R., et al. (2003). Development of an interactive decision aid for female BRCA1/BRCA2 carriers. Journal of Genetic Counseling, 12, 109-129.
35. Kelly, K. M., & Sweet, K. (2007). In search of a familial cancer risk assessment tool. Clinical Genetics, 71, 76-83.
36. Kirchhoff, T., Satagopan, J. M., Kauff, N. D., Huang, H., Kolachana, P., & Palmer, C., et al. (2004). Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. Journal of the National Cancer Institute, 96, 68-70.
37. Koil, C. E., Everett, J. N., Hoechstetter, L., Ricer, R. E., & Huelsman, K. M. (2003). Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genetics in Medicine, 5, 364-369.
38. Kwate, N. O. A., Thompson, H. S., Valdimarsdottir, H. B., & Bjovberg, D. H. (2005). Etiological attributions for breast cancer among healthy African American and European American women. Psycho-oncology, 14, 421-425.
39. Lasset, C., Charavel, M., & Bonadona, V. (2007). Focus group approach for developing written patient information in oncogenetics. Genetic Testing, 11, 193-197.
40. Lee, R., Beattie, M., Crawford, B., Mak, J., Stewart, N., & Komaromy, M., et al. (2005). Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital. Genetic Testing, 9, 306-312.
41. Lobb, E. A., Butow, P. N., Moore, A., Barratt, A., Tucker, K., & Gaff, C., et al. (2006). Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: A pilot study. Journal of Genetic Counseling, 15, 393-405.
42. Lynch, H. T., Follett, K. L., Lynch, P. M., Albano, W. A., Mailliard, J. L., & Pierson, R. L. (1979). Family history in an oncology clinic. Journal of the American Medical Association, 242, 1268-1272.
43. McCaul, K. D., & O'Donnell, S. M. (1998). Naïve beliefs about breast cancer risk. Women's Health, 4, 93-101.
44. Medalie, J. H., Zyzanski, S. J., Langa, D., & Stange, K. C. (1998). The family in family practice: Is it a reality. Journal of Family Practice, 46, 390-396.
45. Metcalfe, K. A., Poll, A., O'Connor, A., Gershman, S., Armel, S., & Finch, A., et al. (2007). Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics, 72, 208-217.
46. Miesfeldt, S., Cohn, W., Ropka, M., & Jones, S. (2001). Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors. Familial Cancer, 1, 135-141.
47. Mogilner, A., Otten, M., Cunningham, J. D., & Brower, S. T. (1998). Awareness and attitudes concerning BRCA gene testing. Annals of Surgical Oncology, 5, 607-612.
48. Mouchawar, J., Byers, T., Cutter, G., Dignan, M., & Michael, S. (1999). A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites. Cancer Detection and Prevention, 23, 22-30.
49. Murff, H. J., Byrne, D., & Syngal, S. (2004). Cancer risk assessment: quality and impact of the family history interview. American Journal of Preventive Medicine, 27, 239-245.
50. Niell, B. L., Rennert, G., Bonner, J. D., Almog, R., Tomsho, L. P., & Gruber, S. B. (2004). BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. Journal of the National Cancer Institute, 96, 15-21.
51. Nusbaum, R., & Isaacs, C. (2007). Management updates for women with a BRCA1 or BRCA2 mutation. Molecular Diagnosis & Therapy, 11, 133-144.
52. Oldenburg, R. A., Meijers-Heijboer, H., Cornelisse, C. J., & Devilee, P. (2007). Genetic susceptibility for breast cancer: How many more genes to be found. Critical Reviews in Oncology/Hematology, 63, 125-149.
53. Palomaki, G. E., McClain, M. R., Steinort, K., Sifri, R., LoPresti, L., & Haddow, J. E. (2006). Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women. Genetics in Medicine, 8, 161-168.
54. Sifri, R., Myers, R., Hyslop, T., Turner, B., Cocroft, J., Rothermel, T. J., & Schlackman, N., et al. (2003). Use of cancer susceptibility testing among primary care physicians. Clinical Genetics, 64, 355-360.
55. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., & McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.
56. Sweet, K. M., Bradley, T. L., & Westman, J. A. (2002). Identification and referral of families at high risk for cancer susceptibility. Journal of Clinical Oncology, 20, 528-537.
57. Tambor, E. S., Rimer, B. K., & Strigo, T. S. (1997). Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. American Journal of Medical Genetics, 68, 43-49.
58. Thompson, D., & Easton, D. F. (2002). Cancer incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute, 94, 1358-1365.
59. Thompson, H. S., Wahl, E., Fatone, A., Brown, K., Kwate, N. O. A., & Valdimarsdottir, H. (2004). Enhancing the readability of materials describing genetic risk for breast cancer. Cancer Control, 11, 245-253.
60. Thompson, J. A., Wiesner, G. L., Sellers, T. A., Vachon, C., Ahrens, M., & Potter, J. D., et al. (1995). Genetic services for familial cancer patients: A survey of National Cancer Institute Cancer Centers. Journal of the National Cancer Institute, 87, 1446-1450.
61. van Roosmalen, M. S., Stalmeier, P. F. M., Verhoef, L. C. G., Hoekstra-Weebers, J. E. H. M., Oosterwijk, J. C., & Hoogerbrugge, N., et al. (2004a). Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90, 333-342.
62. van Roosmalen, M. S., Stalmeier, P. F. M., Verhoef, L. C. G., Hoekstra-Weebers, J. E. H. M., Oosterwijk, J. C., & Hoogerbrugge, N., et al. (2004b). Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22, 3293-3301.
63. Vukovic, N., Harris, E. L., Valanis, B., & Stewart, B. (2002). Consumer knowledge and opinions of genetic testing for breast cancer risk. Clinical Journal of Women's Health, 2, 58-64.
64. Wakefield, C. E., Meiser, B., Homewood, J., Peate, M., Kirk, J., & Warner, B., et al. (2007). Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling, 16, 325-339.
65. Washburn, N. J., Sommer, V. K., Spencer, S. E., Simmons, S. K., Adkins, B. W., & Rogers, M. R., et al. (2005). Outpatient genetic risk assessment in women with breast cancer: one center's experience. Clinical Journal of Oncology Nursing, 9, 49-53.
66. West, D. S., Greene, P. G., Kratt, P. P., Palley, L., Siegfried, N., & Gore, S. A. (2003). The impact of a family history of breast cancer on screening practices and attitudes in low-income, rural, African American women. Journal of Women's Health, 12, 779-787.
67. Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C. N., Davis, W., & Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiology, Biomarkers & Prevention, 12, 295-303.
68. Wilkins-Haug, L., Erickson, K., Hill, L., Power, M., Holzman, G. B., & Schulkin, J. (2000). Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health. Journal of Women's Health & Gender-Based Medicine, 9, 873-879.
69. Wold, K. S., Byers, T., Crane, L. A., & Ahnen, A. (2005). What do cancer survivors believe causes cancer? (United States). Cancer Causes Control, 16, 115-123.